
Mdr1a-Bcrp knockout rats
Related publications
ADMET
ADMET
Fuchs H, Kishimoto W, Gansser D, Tanswell P, Ishiguro N.,
Brain penetration of WEB 2086 (Apafant) and dantrolene in Mdr1a (P-glycoprotein) and Bcrp knockout rats.,
Drug Metab Dispos. 2014 Oct;42(10):1761-5. doi: 10.1124/dmd.114.058545.Epub 2014 Jul 22.
Huang L, Li X, Roberts J, Janosky B, Lin MH.,
Differential role of P-glycoprotein and breast cancer resistance protein in drug distribution into brain, CSF and peripheral nerve tissues in rats.,
Xenobiotica. 2015;45(6):547-55. doi: 10.3109/00498254.2014.997324.
Miyake T.,
Estimating Efflux Transporter-Mediated Disposition of Molecules beyond the Rule of Five (bRo5) Using Transporter Gene Knockout Rats.,
Biol Pharm Bull. 2020 Mar 1;43(3):384-392.
Sato S, Tohyama K, Kosugi Y.,
Investigation of MDR1-overexpressing cell lines to derive a quantitative prediction approach for brain disposition using in vitro efflux activities.,
Eur J Pharm Sci. 2020 Jan 15;142:105119.
Ganguly S, Panetta JC, Roberts JK, Schuetz EG.,
Ketamine Pharmacokinetics and Pharmacodynamics Are Altered by P-Glycoprotein and Breast Cancer Resistance Protein Efflux Transporters in Mice.,
Drug Metab Dispos. 2018 Jul;46(7):1014-1022. doi: 10.1124/dmd.117.078360. Epub 2018 Apr 19.